S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 10.93 CNY -1.09%
Market Cap: 13.6B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Current Assets 10.7B
Cash & Short-Term Investments 2.7B
Receivables 1.8B
Other Current Assets 6.2B
Non-Current Assets 7.9B
Long-Term Investments 1.9B
PP&E 2.6B
Intangibles 2.8B
Other Non-Current Assets 492.1m
Current Liabilities 4.5B
Accounts Payable 378.2m
Accrued Liabilities 147.8m
Short-Term Debt 1.6B
Other Current Liabilities 2.3B
Non-Current Liabilities 2B
Long-Term Debt 1.6B
Other Non-Current Liabilities 388.4m

Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4 126
4 187
4 549
3 597
1 863
1 216
2 712
2 933
2 139
1 766
Cash
0
1
1
0
0
0
0
1 480
1 320
1 766
Cash Equivalents
4 126
4 186
4 548
3 597
1 863
1 216
2 712
1 453
819
0
Short-Term Investments
0
0
13
0
77
113
828
941
2 014
500
Total Receivables
477
575
729
1 122
1 377
1 752
2 026
1 938
1 927
1 529
Accounts Receivables
383
461
481
701
1 084
1 294
1 659
1 533
1 618
1 271
Other Receivables
94
114
248
421
293
458
367
405
309
257
Inventory
884
570
585
1 285
1 659
2 374
3 168
4 708
6 844
6 654
Other Current Assets
1 271
1 150
827
578
623
540
394
251
285
155
Total Current Assets
6 758
6 482
6 703
6 583
5 599
5 996
9 129
10 770
12 390
10 604
PP&E Net
895
1 103
1 223
1 881
2 439
2 576
2 571
2 537
2 477
2 634
PP&E Gross
895
1 103
1 223
1 881
2 439
2 576
2 571
2 537
2 477
2 634
Accumulated Depreciation
143
216
321
516
705
900
1 049
1 261
1 555
1 868
Intangible Assets
174
706
706
720
745
683
631
587
572
493
Goodwill
1 298
2 192
2 342
2 206
2 317
2 355
2 203
2 152
2 351
2 322
Note Receivable
0
0
0
3
8
0
3
2
1
1
Long-Term Investments
604
1 377
1 485
2 083
1 985
3 280
3 999
2 618
2 464
2 514
Other Long-Term Assets
202
308
454
644
509
354
491
443
561
635
Other Assets
1 298
2 192
2 342
2 206
2 317
2 355
2 203
2 152
2 351
2 322
Total Assets
9 930
N/A
12 168
+23%
12 914
+6%
14 119
+9%
13 602
-4%
15 242
+12%
19 026
+25%
19 108
+0%
20 816
+9%
19 203
-8%
Liabilities
Accounts Payable
98
99
71
164
205
229
239
386
427
302
Accrued Liabilities
56
74
85
122
230
184
222
203
199
191
Short-Term Debt
4
50
508
1 843
1 981
2 927
1 860
1 886
2 385
1 881
Current Portion of Long-Term Debt
0
607
1 318
1 572
482
1 012
648
1 414
1 671
1 782
Other Current Liabilities
29
91
84
116
1 764
615
644
903
893
831
Total Current Liabilities
186
920
2 066
3 817
4 663
4 967
3 613
4 791
5 576
4 986
Long-Term Debt
1 005
1 785
2 095
1 824
2 449
2 355
3 137
2 354
2 407
1 900
Deferred Income Tax
270
544
547
317
197
302
428
275
329
253
Minority Interest
83
74
117
200
177
124
120
112
97
75
Other Liabilities
116
126
116
129
126
147
159
164
94
76
Total Liabilities
1 661
N/A
3 449
+108%
4 942
+43%
6 288
+27%
7 612
+21%
7 895
+4%
7 457
-6%
7 697
+3%
8 503
+10%
7 290
-14%
Equity
Common Stock
800
800
1 247
1 247
1 247
1 247
1 467
1 467
1 467
1 467
Retained Earnings
1 799
2 139
2 068
1 898
2 394
3 411
4 212
4 184
4 861
3 931
Additional Paid In Capital
5 278
5 278
4 219
4 462
2 304
2 634
6 035
5 944
5 859
6 356
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
85
94
Treasury Stock
0
116
0
0
0
0
0
0
0
0
Other Equity
392
618
437
224
45
55
145
183
210
252
Total Equity
8 270
N/A
8 719
+5%
7 971
-9%
7 831
-2%
5 990
-24%
7 347
+23%
11 569
+57%
11 411
-1%
12 313
+8%
11 913
-3%
Total Liabilities & Equity
9 930
N/A
12 168
+23%
12 914
+6%
14 119
+9%
13 602
-4%
15 242
+12%
19 026
+25%
19 108
+0%
20 816
+9%
19 203
-8%
Shares Outstanding
Common Shares Outstanding
1 280
1 274
1 247
1 247
1 247
1 247
1 467
1 467
1 467
1 467

See Also

Discover More